 SOUTH SAN FRANCISCO, Calif., Dec. 21, 2021 GLOBE NEWSWIRE -- Aligos Therapeutics, Inc. Nasdaq: ALGS, a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 5:15 pm ET. Both the presentation and the QA session will be held virtually. 